The field trial on an international cross-border scale: The 2015 mHealth Grand Tour summary report

The 2015 mHealth Grand Tour from Brussels to Geneva was a field trial on an international cross-border scale. More than 23 cyclists with Type 1 diabetes were among over 100 riders from 22 nations to take part in the 1,500 kilometer route incorporating more than 22,000 meters of climbing. The ten-day Tour was designed to test how innovative new mobile health solutions can help both athletes and ordinary people better manage their diabetes. This report summarises the performance of the Tour’s mobile health devices and records the experiences of Team GSMA.
Mobile Operator Orange, the Tour’s main sponsor, brought together leading global technology companies Intel, Dexcom, Polar and Samsung, as well as innovative startups TAPcheck, Tellspec and Medwhat, to offer the riders a completely new monitoring and personalised mobile coaching service – significantly more advanced solution than that tested in the inaugural mHealth Grand Tour in 2013
The mHealth Grand Tour 2015 demonstrated that significant progress has been made in developing connected healthcare solutions since the inaugural Tour in 2013. But this exciting new sector is only at the start of long and rewarding journey.
Benjamin Sarda, Head of Marketing, Orange Healthcare, will be discussing the Grand Tour at the 2015 mHealth Summit in Washington DC at 9:30am, Wednesday, Nov 11. His session, ‘The mHealth Grand Tour is A Unique, Living Example of the Power of mobile Health. Why?’ will explore how the remote monitoring of patients with chronic diseases can dramatically improve an individual’s quality of life. Remote monitoring allows patients to maintain independence, reduce the number of times they visit their healthcare provider in-clinic, prevent complications and minimize personal costs.
Register for the 2015 mHealth Summit
Download the 2015 mHealth Grand Tour summary report, ‘Epic Tour Tests Mobile Health’